
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Acid suppression (Adults) (Ranitidine - Acid suppression (Adults))
Records returned : 16 (on 29 May 2025 at 11:25:15).
Return to search results for ' Acid suppression (Adults) '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
1st line for patients with no swallowing difficulties.
2nd line for adults with swallowing difficulties / feeding tubes - capsules can be opened.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Preferred
1st line in adults with swallowing difficulties.
1st line for patients with enteral feeding tubes.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Liquid
- Oral solution
- Oral suspension
Restrictions / Comments:
Important
Lansoprazole oro-dispersible tablets are 1st-line for adults with swallowing dificulties or enteral feeding tubes.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
1st line for patients with no swallowing difficulties.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Tablets
Restrictions / Comments:
Important
Omeprazole or lansoprazole capsules are 1st-line.
Pantoprazole or rabeprazole tablets are 2nd-line for patients without swallowing difficulties (suitable for patients that cannot have animal-derived products).
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Oral suspension
- Oro-dispersible
Restrictions / Comments:
Important
Omeprazole capsules can be opened for patients with swallowing difficulties.
Lansoprazole oro-dispersible tablets are 1st-line for patients with enteral feeding tubes
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Reserve for use where a PPI AND and other H2RAs are not suitable OR where a liquid preparation is required.
Check for drug interactions.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Granules
Restrictions / Comments:
Important
Lansoprazole oro-dispersible 1st-line. Esomeprazole is 3rd-line. Restricted to patients with swallowing difficulties or with large bore enteral feeding tube when other options are not clinically appropriate. Do not use in tubes less than 6F.
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Capsules
Restrictions / Comments:
Important
Lansoprazole capsules are the preferred option.
Esomeprazole 40mg restricted to short-term use or for Zollinger-Ellison syndrome.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
For use where a PPI is not suitable and an H2RA is indicated.
For doses of 300mg, please prescribe 2x150mg as this is considerably more cost effective.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Tablets
Restrictions / Comments:
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
Links :
Indication :
Status :
Amber
Restrictions / Comments:
Formulary Status :
Links :